Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Meningococcal C Vaccine Programmes in Canadian (BC, NS, Alta.) Children During Peak Years of Risk (0-<5 Years of Age)

NCT00936962 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00936962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00936962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Meningococcal C Vaccine Programmes in Canadian (BC, NS, Alta.) Children During Peak Years of Risk (0-<5 Years of Age)
Lead sponsor
University of British Columbia
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2009
Completion date
June 30, 2015
Enrollment
452 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal sero-type c infection